Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Alexander

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|August 16, 2017
The potential efficacy of GABA<sub>B</sub> antagonists in depressionRobert C Alexander
The Journal of Prevention of Alzheimer'S Disease|August 1, 2025
Gene and genetic therapies in Alzheimer's disease and other dementiasRobert C Alexander
Current Opinion in Pharmacology|February 26, 2014
Clinical pharmacology in the development of new antidepressants: the challengesRobert C Alexander, Sheldon Preskorn
Innovations in Clinical Neuroscience|December 14, 2019
Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression StudiesMark E Whitlock, Philip W Woodward, Robert C Alexander
Convulsive Therapy|January 1, 1988
Convulsive Therapy in the Treatment of Mania: McLean Hospital 1973-1986Robert C. Alexander, Melinda Salomon, Martin Ionescu-Pioggia, et al.
The Clinical Journal of Pain|October 21, 2020
A 3-way Cross-over Study of Pregabalin, Placebo, and the Histamine 3 Receptor Inverse Agonist AZD5213 in Combination With Pregabalin in Patients With Painful Diabetic Neuropathy and Good Pain-reporting AbilityRobert C Alexander, Karen Raudibaugh, Egilius L H Spierings, et al.
The Lancet. Neurology|March 2, 2026
Clarifications on our Policy ViewEric M Reiman, Robert C Alexander, Jessica B Langbaum, et al.
Clinical Neurology and Neurosurgery|January 14, 2025
Response to "Anti-amyloid-beta treatments in Alzheimer's disease: When neurologists turn into cheerleaders"Robert C Alexander, Eric M Reiman, Jeffrey L Cummings, et al.
The Lancet. Neurology|January 24, 2024
A chance to prevent Alzheimer's disease sooner than you thinkEric M Reiman, Jeffrey L Cummings, Jessica B Langbaum, et al.
Journal of Clinical Psychopharmacology|August 6, 2015
Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications DevelopmentDavid J McCann, Nancy M Petry, Anders Bresell, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|August 16, 2017
The potential efficacy of GABA<sub>B</sub> antagonists in depressionRobert C Alexander
The Journal of Prevention of Alzheimer'S Disease|August 1, 2025
Gene and genetic therapies in Alzheimer's disease and other dementiasRobert C Alexander
Current Opinion in Pharmacology|February 26, 2014
Clinical pharmacology in the development of new antidepressants: the challengesRobert C Alexander, Sheldon Preskorn
Innovations in Clinical Neuroscience|December 14, 2019
Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression StudiesMark E Whitlock, Philip W Woodward, Robert C Alexander
Convulsive Therapy|January 1, 1988
Convulsive Therapy in the Treatment of Mania: McLean Hospital 1973-1986Robert C. Alexander, Melinda Salomon, Martin Ionescu-Pioggia, et al.
The Clinical Journal of Pain|October 21, 2020
A 3-way Cross-over Study of Pregabalin, Placebo, and the Histamine 3 Receptor Inverse Agonist AZD5213 in Combination With Pregabalin in Patients With Painful Diabetic Neuropathy and Good Pain-reporting AbilityRobert C Alexander, Karen Raudibaugh, Egilius L H Spierings, et al.
The Lancet. Neurology|March 2, 2026
Clarifications on our Policy ViewEric M Reiman, Robert C Alexander, Jessica B Langbaum, et al.
Clinical Neurology and Neurosurgery|January 14, 2025
Response to "Anti-amyloid-beta treatments in Alzheimer's disease: When neurologists turn into cheerleaders"Robert C Alexander, Eric M Reiman, Jeffrey L Cummings, et al.
The Lancet. Neurology|January 24, 2024
A chance to prevent Alzheimer's disease sooner than you thinkEric M Reiman, Jeffrey L Cummings, Jessica B Langbaum, et al.
Journal of Clinical Psychopharmacology|August 6, 2015
Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications DevelopmentDavid J McCann, Nancy M Petry, Anders Bresell, et al.
Pageof 2